SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001019687-11-002252
Filing Date
2011-07-14
Accepted
2011-07-14 16:31:35
Documents
8
Period of Report
2011-04-30

Document Format Files

Seq Description Document Type Size
1 PEREGRINE 10-K peregrine_10k-043011.htm 10-K 1938265
2 FORM OF STOCK ISSUANCE AGREEMENT peregrine_10k-ex0415.htm EX-4.15 65899
3 ANNUAL BONUS PLAN peregrine_10k-ex1029.htm EX-10.29 5512
4 SUBSIDIARIES peregrine_10k-ex21.htm EX-21 3487
5 CONSENT peregrine_10k-ex2301.htm EX-23.1 3429
6 CERTIFICATION peregrine_10k-ex3101.htm EX-31.1 10461
7 CERTIFICATION peregrine_10k-ex3102.htm EX-31.2 10710
8 CERTIFICATION peregrine_10k-ex32.htm EX-32 11013
  Complete submission text file 0001019687-11-002252.txt   2049950
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-32839 | Film No.: 11968269
SIC: 2834 Pharmaceutical Preparations